Celularity Faces Nasdaq Compliance Warning Over Delayed Financial Filings
Biotechnology company Celularity has received a non-compliance notice from Nasdaq after failing to submit its required quarterly 10-Q financial report on time. The company is now working to rectify the filing delays to maintain its exchange listing status.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (32/100)Sources
Celularity receives Nasdaq non-compliance notice over delayed 10-Q filings
Read full article →Celularity Provides Update Regarding Nasdaq Listing Compliance - Taiwan News
Celularity Provides Update Regarding Nasdaq Listing Compliance Taiwan News
Read full article →


